Workflow
财报分析
icon
Search documents
ST雪发2025年中报简析:净利润同比下降9.93%
Zheng Quan Zhi Xing· 2025-08-30 23:27
Financial Performance - ST Xuefa reported a net profit decline of 9.93% year-on-year, with a total revenue of 386 million yuan, down 7.77% compared to the previous year [1] - The second quarter revenue was 168 million yuan, reflecting a significant year-on-year decrease of 32.9, while the net profit for the same period was -13.14 million yuan, showing a slight increase of 1.34% year-on-year [1] - The gross margin was -6.79%, a decrease of 242.3% year-on-year, and the net margin was -5.65%, down 18.87% year-on-year [1] Cost and Expenses - Total sales, management, and financial expenses amounted to 29.54 million yuan, accounting for 7.65% of revenue, which is an increase of 1.28% year-on-year [1] - The company reported a per-share net asset value of 2.21 yuan, down 11.43% year-on-year, and a per-share operating cash flow of -0.11 yuan, which is an increase of 29.05% year-on-year [1] Historical Performance and Investment Return - The company's historical financial performance has been generally poor, with a median ROIC of 1.2% over the past decade and a worst year ROIC of -16.22% in 2021 [3] - The company has reported losses in 6 out of 14 annual reports since its listing, indicating weak investment returns [3] Cash Flow and Debt Management - The company has a healthy cash position, with cash assets being sufficient [3] - However, the cash flow situation is concerning, with a cash asset to current liabilities ratio of only 48.61% and negative average operating cash flow over the past three years [3]
热景生物2025年中报简析:净利润同比下降93.24%,三费占比上升明显
Zheng Quan Zhi Xing· 2025-08-30 23:27
本次财报公布的各项数据指标表现不尽如人意。其中,毛利率56.18%,同比增12.41%,净利 率-41.67%,同比减127.06%,销售费用、管理费用、财务费用总计1.32亿元,三费占营收比64.91%,同 比增36.49%,每股净资产31.69元,同比减8.6%,每股经营性现金流0.19元,同比增551.28%,每股收 益-0.93元,同比减97.87% 据证券之星公开数据整理,近期热景生物(688068)发布2025年中报。截至本报告期末,公司营业总收 入2.04亿元,同比下降18.04%,归母净利润-8399.78万元,同比下降93.24%。按单季度数据看,第二季 度营业总收入1.11亿元,同比下降16.59%,第二季度归母净利润-5998.96万元,同比下降23.63%。本报 告期热景生物三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达36.49%。 | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 2.49亿 | 2.04亿 | -18.04% | | 归母净利润(元) | -434 ...
至纯科技2025年中报简析:增收不增利,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:27
据证券之星公开数据整理,近期至纯科技(603690)发布2025年中报。截至本报告期末,公司营业总收 入16.08亿元,同比上升5.25%,归母净利润3931.87万元,同比下降46.68%。按单季度数据看,第二季 度营业总收入8.8亿元,同比上升22.88%,第二季度归母净利润2030.26万元,同比上升99.87%。本报告 期至纯科技公司应收账款体量较大,当期应收账款占最新年报归母净利润比达12949%。 本次财报公布的各项数据指标表现一般。其中,毛利率30.03%,同比减12.4%,净利率0.65%,同比减 77.36%,销售费用、管理费用、财务费用总计3.44亿元,三费占营收比21.4%,同比减2.88%,每股净资 产13.07元,同比增1.87%,每股经营性现金流-1.47元,同比减11.62%,每股收益0.1元,同比减46.63% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 15.28亿 | 16.08亿 | 5.25% | | 归母浄利润(元) | 7374.34万 | 3931.87万 | - ...
盛通股份2025年中报简析:亏损收窄
Zheng Quan Zhi Xing· 2025-08-30 23:27
Core Viewpoint - The financial report of Shengtong Co., Ltd. (002599) for the first half of 2025 shows a narrowing loss, with total revenue declining slightly and a significant improvement in net profit compared to the previous year [1] Financial Performance Summary - Total revenue for the first half of 2025 was 982 million yuan, a decrease of 2.86% year-on-year [1] - The net profit attributable to shareholders was -6.57 million yuan, an improvement of 59.18% year-on-year [1] - In Q2 2025, total revenue was 528 million yuan, a slight increase of 0.02% year-on-year, while net profit attributable to shareholders was 3.41 million yuan, up 142.56% year-on-year [1] Key Financial Ratios - Gross margin was 14.29%, down 2.66% year-on-year [1] - Net margin was -0.66%, an improvement of 58.80% year-on-year [1] - Total selling, administrative, and financial expenses amounted to 128 million yuan, accounting for 13.08% of revenue, a decrease of 7.77% year-on-year [1] Cash Flow and Assets - Cash flow per share was 0.11 yuan, a significant increase of 1663.44% year-on-year [1] - The company's net asset value per share was 2.28 yuan, down 14.24% year-on-year [1] - The company had 202 million yuan in cash and cash equivalents, a decrease of 17.38% year-on-year [1] Historical Performance Insights - The company's historical return on invested capital (ROIC) has been weak, with a median of 3.5% over the past decade and a worst year ROIC of -20.91% in 2020 [3] - The company has reported losses in 2 out of 13 annual reports since its listing, indicating a fragile business model [3] - The cash flow situation is concerning, with cash and cash equivalents covering only 31.51% of current liabilities [3]
路德环境2025年中报简析:增收不增利,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:27
Core Viewpoint - The financial performance of Lude Environment (688156) for the first half of 2025 shows a slight increase in revenue but significant losses in net profit, indicating potential challenges in its business model and financial health [1][2]. Financial Performance - Total revenue for the reporting period reached 147 million yuan, a year-on-year increase of 1.08% [1] - Net profit attributable to shareholders was -13.07 million yuan, a year-on-year decline of 969.04% [1] - In Q2, total revenue was 83.89 million yuan, up 8.32% year-on-year, while net profit was -14.43 million yuan, down 243.65% year-on-year [1] - Gross margin stood at 18.93%, a decrease of 44.28% year-on-year, and net margin was -8.0%, down 1243.96% year-on-year [1] - Total expenses (selling, administrative, and financial) amounted to 44.67 million yuan, accounting for 30.4% of revenue, an increase of 20.99% year-on-year [1] - Earnings per share were -0.13 yuan, a decrease of 1400.0% year-on-year [1] Business Model and Investment Returns - The company's net margin last year was -24.13%, indicating low added value in its products or services [2] - Historical data shows a median ROIC of 8.85%, with the worst year being 2024 at -4.4%, reflecting poor investment returns [2] - The company has reported losses in two out of four annual reports since its listing, suggesting a fragile business model [2] Cash Flow and Debt Situation - Cash flow metrics indicate that cash and cash equivalents represent only 9.86% of total assets and 46.81% of current liabilities [3] - The interest-bearing debt ratio has reached 30.83%, with total interest-bearing liabilities to the average operating cash flow over the past three years at 41.39% [3] - Financial expenses account for 77.19% of the average operating cash flow over the past three years, raising concerns about financial sustainability [3] Analyst Expectations - Analysts project a performance of 7 million yuan for 2025, with an average earnings per share of 0.07 yuan [4]
千金药业2025年中报简析:净利润同比增长8.5%,盈利能力上升
Zheng Quan Zhi Xing· 2025-08-30 23:27
Group 1 - The core viewpoint of the news is that Qianjin Pharmaceutical (600479) reported a decline in total revenue but an increase in net profit for the first half of 2025 compared to the same period in 2024 [1] - The total revenue for the first half of 2025 was 1.818 billion yuan, a decrease of 5.52% year-on-year, while the net profit attributable to shareholders was 128 million yuan, an increase of 8.5% year-on-year [1] - In Q2 2025, the total revenue was 813 million yuan, down 11.97% year-on-year, but the net profit attributable to shareholders was 74.57 million yuan, up 4.26% year-on-year [1] Group 2 - The gross profit margin increased by 10.63% year-on-year to 49.97%, and the net profit margin increased by 23.57% year-on-year to 9.57% [1] - Total expenses (selling, administrative, and financial) amounted to 602 million yuan, accounting for 33.11% of revenue, which is an increase of 14.71% year-on-year [1] - The company's cash flow per share improved by 42.59% year-on-year, reaching -0.1 yuan, while earnings per share increased by 8.46% to 0.3 yuan [1] Group 3 - The company's return on invested capital (ROIC) was 8.46%, indicating average capital returns, with a historical median ROIC of 10.79% over the past decade [3] - The business model relies heavily on research and marketing, necessitating a detailed examination of the underlying drivers [3] - The cash flow situation is a concern, with cash and cash equivalents to current liabilities ratio at 69.05%, and accounts receivable to profit ratio at 148.04% [3]
光明乳业2025年中报简析:净利润同比下降22.53%,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:27
Core Viewpoint - The recent financial report of Bright Dairy (600597) indicates a decline in both revenue and net profit for the first half of 2025, raising concerns about the company's financial health and operational efficiency [1][3]. Financial Performance - The total revenue for the first half of 2025 was 12.472 billion yuan, a decrease of 1.9% year-on-year [1]. - The net profit attributable to shareholders was 217 million yuan, down 22.53% compared to the previous year [1]. - In Q2 2025, total revenue was 6.104 billion yuan, reflecting a 3.06% decline year-on-year, while net profit for the quarter was 76.2 million yuan, a decrease of 29.49% [1]. - The gross margin was 18.85%, down 4.94% year-on-year, while the net margin improved slightly to 1.85%, an increase of 3.37% [1]. - Total expenses (selling, administrative, and financial) amounted to 1.876 billion yuan, accounting for 15.04% of revenue, which is an 8.07% decrease year-on-year [1]. Balance Sheet and Cash Flow - The company reported a significant accounts receivable level, with accounts receivable amounting to 2.494 billion yuan, which is 248.41% of the latest annual net profit [1][4]. - Cash and cash equivalents increased to 2.916 billion yuan, an 8.6% rise year-on-year [1]. - The operating cash flow per share was 0.3 yuan, showing a substantial increase of 82.28% year-on-year [1]. Investment Returns - The company's Return on Invested Capital (ROIC) for the previous year was 4.36%, indicating weak capital returns [3]. - The historical median ROIC over the past decade stands at 6.81%, with the lowest recorded ROIC being 3.52% in 2022 [3]. Market Position and Fund Holdings - The largest fund holding Bright Dairy is the E Fund Yu Hui Fixed Income Mixed A, which has recently entered the top ten holdings with 689,800 shares [5]. - The fund's current scale is 1.603 billion yuan, with a recent net value increase of 0.13% [5].
海航控股2025年中报简析:营收净利润同比双双增长,短期债务压力上升
Zheng Quan Zhi Xing· 2025-08-30 23:27
据证券之星公开数据整理,近期海航控股(600221)发布2025年中报。截至本报告期末,公司营业总收 入330.83亿元,同比上升4.22%,归母净利润5694.5万元,同比上升108.95%。按单季度数据看,第二季 度营业总收入154.82亿元,同比上升9.08%,第二季度归母净利润-2.15亿元,同比上升83.72%。本报告 期海航控股短期债务压力上升,流动比率达0.84。 本次财报公布的各项数据指标表现尚佳。其中,毛利率6.73%,同比减7.36%,净利率0.02%,同比增 101.0%,销售费用、管理费用、财务费用总计33.54亿元,三费占营收比10.14%,同比减21.33%,每股 净资产0.06元,同比增80.09%,每股经营性现金流0.13元,同比减10.95%,每股收益0.0元,同比增 108.84% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 317.43亿 | 330.83亿 | 4.22% | | 归母净利润(元) | -6.36 Z | 5694.5万 | 108.95% | | 扣非 ...
廊坊发展2025年中报简析:净利润同比增长338.69%,盈利能力上升
Zheng Quan Zhi Xing· 2025-08-30 23:27
Core Viewpoint - Langfang Development (600149) reported a mixed performance in its 2025 interim report, with a decline in total revenue but a significant increase in net profit, indicating improved profitability despite revenue challenges [1]. Financial Performance - Total revenue for the first half of 2025 was 98.07 million yuan, a decrease of 4.88% year-on-year [1]. - Net profit attributable to shareholders reached 4.188 million yuan, up 338.69% year-on-year [1]. - In Q2 2025, total revenue was 8.6209 million yuan, down 39.99% year-on-year, while net profit was -2.8471 million yuan, a slight increase of 0.09% year-on-year [1]. - Gross margin improved to 33.31%, an increase of 25.47% year-on-year, and net margin rose to 16.46%, up 48.04% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 10.1105 million yuan, accounting for 10.31% of revenue, a decrease of 20.46% year-on-year [1]. Key Financial Ratios - Earnings per share (EPS) was 0.01 yuan, reflecting a significant increase of 266.67% year-on-year [1]. - The company's return on invested capital (ROIC) was 32.19%, indicating strong capital returns [2]. - The average operating cash flow over the past three years was only 17.47% of current liabilities, suggesting potential liquidity concerns [3]. Asset and Liability Management - Cash and cash equivalents decreased to 195 million yuan, down 24.98% year-on-year [1]. - Accounts receivable increased to 16.1613 million yuan, up 14.19% year-on-year [1]. - Interest-bearing debt was reduced to 48.2363 million yuan, a decrease of 48.01% year-on-year [1].
中体产业2025年中报简析:净利润同比下降207.4%,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:27
Core Insights - The company reported a significant decline in total revenue and net profit for the first half of 2025 compared to the same period in 2024, with total revenue at 787 million yuan, down 25.24%, and a net loss of 24.40 million yuan, a decrease of 207.4% [1][4] - The second quarter showed a positive trend with total revenue of 493 million yuan, an increase of 39.54%, and a net profit of 3.35 million yuan, up 15.24% year-on-year [1][4] - The company's gross margin decreased to 19.42%, down 38.86% year-on-year, while the net margin turned negative at -1.14%, a drop of 114.74% [1][4] Financial Performance - Total revenue for 2024 was 1.053 billion yuan, compared to 787 million yuan in 2025, reflecting a 25.24% decline [1] - The net profit for 2024 was 22.72 million yuan, which turned into a loss of 24.40 million yuan in 2025, marking a 207.4% decrease [1] - The company's gross margin fell from 31.76% in 2024 to 19.42% in 2025, indicating a significant reduction in profitability [1] - The net margin shifted from 7.70% in 2024 to -1.14% in 2025, highlighting a severe decline in financial health [1] Accounts Receivable and Cash Flow - The accounts receivable reached a concerning level, with accounts receivable to net profit ratio at 247.74%, indicating potential liquidity issues [1][4] - The company reported a significant increase in cash assets, with cash and cash equivalents rising to 2.072 billion yuan, a 15.41% increase year-on-year [1] Business Model and Return on Investment - The company's return on invested capital (ROIC) was reported at 3.89%, indicating weak capital returns, with a historical median ROIC of 2.67% over the past decade [3] - The net profit margin for the previous year was 8.03%, suggesting that the company's products or services have average added value [3]